PCBL Chemical Limited — Others, 10-01-2025: Statement of deviation(s) or variation(s) under Reg. 32

PCBL Chemical Limited has confirmed no deviations in the use of proceeds from the preferential allotment of 1.6 crore warrants, each convertible into an equity share. The company raised ₹112 crore initially, with an additional ₹336 crore anticipated within 18 months, contingent on warrant exercises. For the quarter ended December 31, 2024, no funds were utilized for debt repayment, working capital, or corporate purposes, maintaining a total unutilized amount of ₹336 crore. This clarity enhances investor confidence in fund management, while the lack of operational changes suggests a stable outlook.